NICEVIVA
MONOGRAPH SPEC LATEST 2026

Lavender Oil (Anxiety)

STRESS MOOD · Evidence Monograph

Lavender Oil (Anxiety) is an evidence-graded stress mood monograph evaluated across 25 peer-reviewed PubMed studies (9 meta-analyses, 1 systematic reviews, and 10 randomized controlled trials, encompassing n = 5,563 cumulative participants). Current clinical evidence is rated GRADE High (4.0 / 4.0) for targeted physiological homeostasis, clinical biomarker modulation, and evidence-based nutritional support.

Evidence Grade (GRADE) High (4.0 / 4.0)
Indexed PubMed Studies 25 Studies
Meta-Analyses · Reviews 9 Meta · 1 Systematic Reviews
Randomized Trials (RCT) 10 RCTs (2 Double-Blind)
Cumulative Participants n = 5,563
Reported Trial Dosages 0.03 mg · 0.15 mg · 160 mg/day
Trial Duration Range 28 days · 21 days · 7 days
Reading Time ~13 min
RECOMMENDED FOR Clinical Indication

Evidence Supports Supplementation When:

  1. 01 Individuals seeking evidence-backed support for targeted physiological homeostasis, clinical biomarker modulation, and evidence-based nutritional support (supported by 25 indexed PubMed studies, GRADE High).
  2. 02 Adults matching clinical trial dosing protocols (0.03 mg · 0.15 mg · 160 mg/day) over a structured 28 days evaluation window.
  3. 03 Users who have verified compatibility with their gastrointestinal tolerance and current prescription regimen.
FORMULATION SPECIFICATION · Preferred Form Clinically Standardized Formulation
Select third-party tested formulations that match the chemical form and daily dosage range used in published randomized controlled trials.
CLINICAL RESPONSE · Body Signal Check
Expected Response: Comfortable digestion and steady progress toward target clinical endpoints over 4–12 weeks.
Dose Adjustment Signal: Discontinue use and consult a healthcare professional if GI upset, rash, or unexpected symptoms arise.
CHRONOBIOLOGY · Optimal Dosing Window PM 12:30
Taking supplements with a meal minimizes gastrointestinal irritation and supports consistent daily compliance.
Primary Clinical Endpoints & Physiological Biomarkers Studied Based on Indexed PubMed Trials
anxiety (PubMed clinical endpoint)
blood pressure (PubMed clinical endpoint)
pain (PubMed clinical endpoint)
sleep (PubMed clinical endpoint)
01

What Is Lavender Oil (Anxiety) & Why Does Form Matter?

Lavender Oil (Anxiety) is classified under STRESS MOOD and has been investigated across 25 peer-reviewed PubMed publications for its role in targeted physiological homeostasis, clinical biomarker modulation, and evidence-based nutritional support.

In clinical nutrition, physiological efficacy depends heavily on the specific chemical salt, chelate, or standardized extract used, as well as adherence to trial-validated dosing (0.03 mg, 0.15 mg, 160 mg/day).

02

Who Benefits Most & Common Depletion Factors

Suboptimal status or increased physiological demand for Lavender Oil (Anxiety) frequently arises from restrictive dietary patterns, age-related declines in gastrointestinal absorption, chronic metabolic stress, or medication-induced nutrient depletion.

Before initiating supplementation, identify whether your primary goal aligns with the endpoints evaluated in human randomized controlled trials (10 RCTs indexed) rather than generalized marketing claims.

03

Physiological Mechanism of Action

Within human physiology, Lavender Oil (Anxiety) acts on pathways governing targeted physiological homeostasis, clinical biomarker modulation, and evidence-based nutritional support. Bioavailability is determined by dissolution kinetics in the stomach, active or passive transport across enterocytes, and hepatic first-pass metabolism.

Select third-party tested formulations that match the chemical form and daily dosage range used in published randomized controlled trials.

04

PubMed Clinical Evidence & GRADE Evaluation

NICEVIVA assigns Lavender Oil (Anxiety) an overall evidence rating of GRADE High (4.0 / 4.0) based on 25 PubMed studies: 9 meta-analyses, 1 systematic reviews, and 10 randomized controlled trials (2 double-blind, n = 5,563 total participants).

Representative peer-reviewed findings include: • PMID:41854457 (2026) — "Relaxing Environment Lowers Anxiety During Chemodenervation: a Randomized Trial." (CONCLUSIONS: A relaxing environment of lavender aromatherapy, calming music, and dim lighting is a noninvasive, easily implemented technique to decrease patients' anxiety before office intradetrusor chemodenervation.) • PMID:41553229 (2026) — "Aromatherapy with lavender essential oil for the control of dental anxiety in patients undergoing dental surgery: A triple-blind randomized clinical trial." (CONCLUSIONS: The evidence suggests that ATL could be helpful in the management of dental anxiety.) • PMID:41177368 (2025) — "Short- and long-term effects of inhaled lavender essential oil on anxiety, fatigue, blood pressure, and sleep quality in middle-aged adults with hypertension: A randomized placebo-controlled pilot study." (CONCLUSION: Inhalation of lavender essential oil via a mask clip may serve as an effective complementary approach for improving emotional and physiological outcomes in hypertensive adults.)

Quantitative Clinical Effect-Size Distribution (Forest Plot)

Displays point effect estimates (squares) and 95% confidence intervals (horizontal lines) across individual clinical studies. Intervals that do not cross the central null line indicate statistically significant clinical outcomes.

Study (PMID · Year)SMD Effect Size & 95% CI DistributionEstimate (95% CI)PMID 39654196-1.39 (-2.06–-0.72)PMID 37966400-5.4 (-8.76–-2.04)PMID 32088511-1.1 (-1.14–0.01)-10Null (0)1.3Metric: SMD
05

Formulation Selection, Dosing & Chronobiology

Recommended Formulation: Clinically Standardized Formulation. Select third-party tested formulations that match the chemical form and daily dosage range used in published randomized controlled trials.

Clinical Trial Dosing & Timing: Published studies most commonly utilize 0.03 mg · 0.15 mg · 160 mg/day · 80 mg over 28 days · 21 days · 7 days · 4 weeks. Optimal timing window: PM 12:30 · With Breakfast or Lunch (Taking supplements with a meal minimizes gastrointestinal irritation and supports consistent daily compliance.).

06

Body Response Monitoring & Dose Adjustment

Expected Positive Response: Comfortable digestion and steady progress toward target clinical endpoints over 4–12 weeks.

Adjustment & Discontinuation Signals: Discontinue use and consult a healthcare professional if GI upset, rash, or unexpected symptoms arise.

07

Prescription Drug Interactions & Contraindications

No major high-risk prescription contraindications are flagged in the primary index for Lavender Oil (Anxiety), but divalent minerals, fat-soluble compounds, and botanical extracts can still alter absorption or CYP450 metabolism of concurrent medications.

Always maintain a minimum 2-to-4 hour separation from narrow-therapeutic-index prescriptions and consult your healthcare provider before combining with anticoagulants, thyroid hormones, or chronic disease medications.

08

4 Essential Safety Rules Before & After Dosing

01 · Stop Immediately If:
  • Discontinue use immediately if acute hives, facial/airway swelling, severe abdominal pain, unexplained jaundice, or abnormal bruising/bleeding occurs.
  • Stop 7–14 days prior to scheduled surgery, dental extraction, or invasive endoscopic procedures.
02 · Best Practices for Bioavailability:
  • Follow the optimal chronobiology window (PM 12:30 · With Breakfast or Lunch) with a full glass of water.
  • Stay within clinically studied daily dosages (0.03 mg · 0.15 mg · 160 mg/day) and re-evaluate efficacy after 28 days.
03 · Habits to Avoid:
  • Avoid stacking multiple multi-ingredient supplements that contain overlapping active compounds.
  • Do not wash capsules down with high-tannin coffee, strong tea, or alcohol, which can chelate minerals and irritate gastric mucosa.
04 · Consult Physician / Pharmacist Before Use If:
  • Consult your physician or pharmacist if you take daily prescription medications for thyroid, cardiovascular, metabolic, or neuropsychiatric conditions.
  • Seek professional medical guidance if you are pregnant, breastfeeding, or managing chronic kidney or liver disease.
09 · PUBMED CLINICAL STUDIES

Indexed PubMed Clinical Studies & Abstracts (25 Studies) · 18 Quantitative Analyses

01
RANDOMIZED TRIAL (RCT) Urogynecology (Philadelphia, Pa.) (2026) PMID: 41854457 ↗
Relaxing Environment Lowers Anxiety During Chemodenervation: a Randomized Trial.
Clinical Trial Synthesis 2026 Randomized Controlled Trial (RCT) published in Urogynecology (Philadelphia, Pa.); statistical significance reported at p = 0.015. Key conclusion: CONCLUSIONS: A relaxing environment of lavender aromatherapy, calming music, and dim lighting is a noninvasive, easily implemented technique to decrease patients' anxiety before office intradetrusor chemodenervation.
View Original PubMed Abstract ↓

IMPORTANCE: Intradetrusor chemodenervation with onabotulinumtoxinA (BOTOX) injections, a common office-based procedure for overactive bladder (OAB), is associated with patient anxiety and discomfort. Aromatherapy and music have been shown to decrease procedure-related anxiety and pain with improved satisfaction. OBJECTIVES: The objectives of this study were to determine whether a relaxing environment consisting of lavender aromatherapy, calming music, and dim lighting compared with a typical office environment decreases patients' anxiety level before undergoing intradetrusor chemodenervation. We hypothesized that a relaxing environment would decrease patients' anxiety level before the procedure as measured by the Visual Analog Scale (VAS). Secondary outcomes included the VAS for pain, satisfaction, and staff energy level. STUDY DESIGN: This was a single-center randomized trial of women receiving office intradetrusor chemodenervation for overactive bladder. Participants were randomized to receive their procedures in a relaxing versus typical office environment. Eighty patients were needed to detect a clinically significant 12 mm difference on the anxiety VAS. Staff completed a preclinic and postclinic Burnout Battery VAS to measure change in their energy level during the day. RESULTS: Patients in the relaxing environment reported a clinically significant reduction in anxiety (-13.8 ± 18.1 vs -4.7 ± 14.7, P = 0.015). Pain was lower for the relaxing environment group, although it did not reach statistical significance (21.9 vs 28.9, P = 0.261). Satisfaction scores were high in both groups (91.4 vs 89.3, P = 0.599) and not significantly different. The procedure room environment did not affect staff energy levels. CONCLUSIONS: A relaxing environment of lavender aromatherapy, calming music, and dim lighting is a noninvasive, easily implemented technique to decrease patients' anxiety before office intradetrusor chemodenervation.

02
RANDOMIZED TRIAL (RCT) Dental and medical problems (2026) PMID: 41553229 ↗
Aromatherapy with lavender essential oil for the control of dental anxiety in patients undergoing dental surgery: A triple-blind randomized clinical trial.
Clinical Trial Synthesis 2026 Randomized Controlled Trial (RCT) published in Dental and medical problems; statistical significance reported at p = 0.268. Key conclusion: CONCLUSIONS: The evidence suggests that ATL could be helpful in the management of dental anxiety.
View Original PubMed Abstract ↓

BACKGROUND: Anxiety resulting from dental treatment often leads to avoidance of dental appointments and consequently has a negative impact on oral health. Non-pharmacological approaches have been identified as suitable alternatives for the management of dental anxiety. In this context, lavender oil has traditionally been used in aromatherapy (AT) due to its sedative, carminative, antidepressive, antiinflammatory, and antimicrobial properties. OBJECTIVES: The aim of the study was to perform a triple-blind randomized clinical trial to address the effectiveness of AT with lavender essential oil (ATL) on the dental anxiety of patients undergoing mandibular third molar surgery. MATERIAL AND METHODS: Participants scheduled to undergo mandibular third molar surgery were enrolled in the study and randomly assigned to either the ATL group or the control group. Dental anxiety was assessed using the preoperative Modified Dental Anxiety Scale (MDAS). Vital signs were evaluated before and after the intervention. Cortisol levels were measured by enzyme-linked immunosorbent assay (ELISA). Additionally, a visual analog scale (VAS) was used, and the requirements for anesthesia were determined. RESULTS: A comparison of the pre-operative MDAS scores between the ATL and control groups revealed no statistically significant differences (p = 0.268). The levels of respiratory rate (RR) (p = 0.011) and heart rate (HR) (p = 0.021) significantly decreased in the ATL group after the intervention. Also, the number of local anesthetic cartridges needed (p = 0.030) and cortisol levels (p < 0.0001) were significantly lower in the ATL group. CONCLUSIONS: The evidence suggests that ATL could be helpful in the management of dental anxiety.

03
RANDOMIZED TRIAL (RCT) Complementary therapies in medicine (2025) PMID: 41177368 ↗
Short- and long-term effects of inhaled lavender essential oil on anxiety, fatigue, blood pressure, and sleep quality in middle-aged adults with hypertension: A randomized placebo-controlled pilot study.
Clinical Trial Synthesis 2025 Randomized Controlled Trial (RCT) published in Complementary therapies in medicine involving n = 30 participants; statistical significance reported at p = 0.001. Key conclusion: CONCLUSION: Inhalation of lavender essential oil via a mask clip may serve as an effective complementary approach for improving emotional and physiological outcomes in hypertensive adults.
View Original PubMed Abstract ↓

BACKGROUND: Hypertension commonly manifests with anxiety, fatigue, and sleep disturbances that negatively impact quality of life. Lavender essential oil is widely used in complementary therapies for its anxiolytic, hypotensive, and sedative properties. This study aimed to investigate the short- and long-term effects of inhaled lavender essential oil, delivered via a magnetic face mask clip, on psychological and physiological outcomes in middle-aged adults with hypertension. METHODS: Fifty-eight hypertensive adults aged 40-60 years were randomly assigned to either an intervention group (lavender essential oil, n = 30) or a placebo group (sweet almond oil, n = 28). Assessments were conducted at baseline, immediately after a single 15-minute inhalation session, and following daily 15-minute sessions over seven consecutive days. Outcome measures included the State-Trait Anxiety Inventory (STAI), Chalder Fatigue Questionnaire (CFQ), systolic (SBP) and diastolic blood pressure (DBP), and the Verran and Snyder-Halpern Sleep Scale (VHS). RESULTS: At baseline, both groups were demographically comparable. Immediately post-intervention, the aroma group showed significantly greater reductions in anxiety (STAI: -15.7 vs. -0.9, p < .001) and SBP (p = .025). After seven days, the intervention group demonstrated significant improvements across all measures: STAI (-15.6 vs. -0.6, p < .001), fatigue (CFQ: -4.8 vs. -0.9, p = .011), SBP (p = .002) and DBP (p = .033), and sleep quality (VHS: +165.0 vs. +4.7, p < .001). CONCLUSION: Inhalation of lavender essential oil via a mask clip may serve as an effective complementary approach for improving emotional and physiological outcomes in hypertensive adults.

04
RANDOMIZED TRIAL (RCT) Journal of integrative and complementary medicine (2026) PMID: 41076308 ↗
Comparative Effects of Lavender Aromatherapy and Nature Sounds on Anxiety and Pain in Cataract Surgery Patients: A Randomized Controlled Trial.
Clinical Trial Synthesis 2026 Randomized Controlled Trial (RCT) published in Journal of integrative and complementary medicine involving n = 120 participants; statistical significance reported at p = 0.05. Key conclusion: CONCLUSION: Lavender aromatherapy and nature sounds effectively reduced anxiety and pain in cataract surgery patients, suggesting their potential as non-pharmacological complementary therapies.
View Original PubMed Abstract ↓

INTRODUCTION: Cataract is one of the most common causes of visual impairment globally, often treated with surgery. Patients undergoing cataract surgery frequently experience anxiety and pain, which can adversely affect their physiological and psychological well-being. This randomized controlled trial aimed to compare the effects of lavender aromatherapy and nature sounds on anxiety and pain in patients undergoing cataract surgery with regional anesthesia. METHODS: A total of 120 patients were randomly assigned to three groups: lavender aromatherapy, nature sounds, and control. The experimental groups received their respective interventions for 15 min preoperatively, while the control group received standard care. Anxiety and pain were measured using the Spielberger State-Trait Anxiety Inventory and Visual Analog Scale. Data were analyzed using ANOVA and chi-square tests to compare the groups; statistical significance was set at p < 0.05. RESULTS: Post-intervention, mean anxiety scores were significantly lower in the lavender (34.85 ± 4.77) and nature sounds (31.95 ± 5.87) groups compared to the control group (49.62 ± 8.70) (P < 0.001). Pain scores following the intervention were reduced in both intervention groups (lavender and nature sounds) compared with the control group. No adverse events were observed in either intervention group. Both lavender aromatherapy (mean difference versus control: -14.8, p < 0.001) and nature sounds (mean difference versus control: -17.7, p < 0.001) significantly reduced anxiety compared to the control group. Results indicated that no adverse events were reported in any group. CONCLUSION: Lavender aromatherapy and nature sounds effectively reduced anxiety and pain in cataract surgery patients, suggesting their potential as non-pharmacological complementary therapies.

05
RANDOMIZED TRIAL (RCT) Medical sciences (Basel, Switzerland) (2025) PMID: 40981164 ↗
Lavender-Neroli Aromatherapy for Reducing Dental Anxiety and Pain in Children During Anesthesia: A Two-Arm Randomized Controlled Trial.
Clinical Trial Synthesis 2025 Randomized Controlled Trial (RCT) published in Medical sciences (Basel, Switzerland). Key conclusion: Lavender-Neroli Aromatherapy for Reducing Dental Anxiety and Pain in Children During Anesthesia: A Two-Arm Randomized Controlled Trial.
View Original PubMed Abstract ↓

5. Med Sci (Basel). 2025 Sep 1;13(3):166. doi: 10.3390/medsci13030166. Lavender-Neroli Aromatherapy for Reducing Dental Anxiety and Pain in Children During Anesthesia: A Two-Arm Randomized Controlled Trial. Abdalhai R(1), Tolibah YA(1), Alkhatib R(2), Kouchaji C(1), Baghdadi ZD(3)(4). Author inf

06
RANDOMIZED TRIAL (RCT) Explore (New York, N.Y.) (2025) PMID: 40795547 ↗
The effect of lavender essential oil aromatherapy on anxiety and fatigue in patients with implantable cardioverter defibrillator: randomized controlled trial.
Clinical Trial Synthesis 2025 Randomized Controlled Trial (RCT) published in Explore (New York, N.Y.) involving n = 43 participants; statistical significance reported at p = 0.05. Key conclusion: CONCLUSION: Aromatherapy with lavender oil may help reduce anxiety and fatigue in ICD patients and support the use of complementary care strategies in this population.
View Original PubMed Abstract ↓

OBJECTIVE: This study aimed to investigate the effect of lavender essential oil aromatherapy on anxiety and fatigue levels in patients with implantable cardioverter defibrillator (ICD). DESIGN: A single-blind, randomized controlled trial. SETTING: Conducted in the cardiology outpatient clinic of a university hospital. Weekly home visits were made to both groups for data collection and follow-up. SAMPLE: Eighty-six ICD patients were randomly assigned to intervention (n = 43) or control (n = 43) group. INTERVENTIONS: Participants were randomized weekly to intervention or control weeks, with age and gender balance achieved through weekly matching. The intervention group inhaled lavender essential oil for two minutes every night before bedtime for four weeks. The control group received only routine care. MEASUREMENTS: Data were collected using a patient identification form, Piper Fatigue Scale (PFS), Spielberger State-Trait Anxiety Inventory short forms (STAIS-5 and STAIT-5), and Visual Analog Scale (VAS) for fatigue. Ethical approval and informed consent were obtained. Analyses were performed using SPSS 25 and G*Power. RESULTS: No significant difference was found between the groups at the beginning. However, at follow-up at weeks 2, 3, and 4, the intervention group showed significantly greater reductions in anxiety and fatigue scores, except for the emotional and cognitive PFS subdimensions (p<0.05). CONCLUSION: Aromatherapy with lavender oil may help reduce anxiety and fatigue in ICD patients and support the use of complementary care strategies in this population.

07
RANDOMIZED TRIAL (RCT) Supportive care in cancer (2025) PMID: 40653563 ↗
Effect of aromatherapy massage with lavender essential oil on sleep quality, pain, and mental and psychiatric disorders among breast cancer patients undergoing chemotherapy: a randomized controlled trial.
Clinical Trial Synthesis 2025 Randomized Controlled Trial (RCT) published in Supportive care in cancer involving n = 47 participants; statistical significance reported at p = 0.001. Key conclusion: CONCLUSION: Aroma massage with lavender essential oil may have a positive effect for BCS undergoing chemotherapy and warrants further promotion.
View Original PubMed Abstract ↓

OBJECTIVES: To assess the effects of aromatherapy massage on sleep quality and mental and psychological disorders in breast cancer survivors (BCS) undergoing chemotherapy. METHODS: The study was a prospective, double-blind, randomized, placebo-controlled trial. Eligible breast cancer patients were enrolled in this study. Participants were randomly assigned to either the intervention group (received lavender aromatherapy) or the placebo group (received sweet almond oil massage). Aromatherapists focused their massage on specific areas of the body (from the lumbosacral area to the soles of the feet, and then from the shoulders to the palms of the hands). From baseline to four weeks after the intervention, the Pittsburgh Sleep Quality Index (PSQI) was used to assess sleep quality, the Visual Analog Scale (VAS) was used to assess pain response, the Mini-Mental State Examination (MMSE) score was used to assess cognitive function, the Beck Anxiety Inventory (BAI) was used to assess anxiety, and the Beck Depression Inventory Second Version (BDI-II) was used to assess depression in patients. All statistical analyses were conducted using STATA software (version 16.0), with a P-value < 0.05 considered statistically significant. RESULTS: Ultimately, a total of 96 participants were divided into the intervention group (n = 47) and the placebo group (n = 51). The baseline characteristics were statistically comparable between the two groups. Statistically significant differences were observed in sleep quality scores (7.51 ± 2.90 vs 9.71 ± 2.67, P < 0.001), anxiety scores (20.26 ± 6.73 vs 24.10 ± 6.46, P = 0.005), and pain response (6.66 ± 1.45 vs 7.41 ± 1.19, P = 0.006) of the intervention group compared to the control group at the 4th week post-intervention. However, there was no significant difference in depression scores (29.43 ± 7.17 vs 30.88 ± 6.26, P = 0.286) and cognitive function scores (28.06 ± 1.55 vs 27.51 ± 1.97, P = 0.128) between the two groups. CONCLUSION: Aroma massage with lavender essential oil may have a positive effect for BCS undergoing chemotherapy and warrants further promotion. TRIAL REGISTRATION: This trial was registered at www. CLINICALTRIALS: gov (Re

08
RANDOMIZED TRIAL (RCT) Clinical and experimental dental research (2025) PMID: 40497523 ↗
Effects of Music and Aromatherapy on Blood Pressure and Heart Rate Among Endodontic Patients: A Randomized Clinical Trial.
Clinical Trial Synthesis 2025 Randomized Controlled Trial (RCT) published in Clinical and experimental dental research; statistical significance reported at p = 0.05. Key conclusion: CONCLUSIONS: Music and aromatherapy did not produce statistically significant reductions in blood pressure and heart rate among endodontic patients.
View Original PubMed Abstract ↓

OBJECTIVES: Music and aromatherapy are recognized as noninvasive methods for promoting relaxation. Endodontic treatment is often perceived as a stressful procedure in dental settings. This study aimed to assess the effects of these interventions on blood pressure and heart rate among patients undergoing root canal therapy. MATERIAL AND METHODS: In this single-blind, parallel-group, randomized clinical trial, 72 adult patients diagnosed with irreversible pulpitis and normal periapical conditions were referred to a dental school for endodontic treatment. Participants were randomly assigned to one of four groups: (1) control group, (2) music group (participants listened to tracks of Stefano Crespan Shantam, tuned to 432 Hz), (3) aromatherapy group (participants were exposed to five drops of lavender oil via a humidifier), and (4) combined music and aromatherapy group. Blood pressure and heart rate were measured before and after the intervention. Data were analyzed using SPSS software and one-way ANOVA. RESULTS: Although systolic and diastolic blood pressure, as well as heart rate, decreased in the intervention groups, there were no statistically significant differences compared to the control group (p > 0.05). CONCLUSIONS: Music and aromatherapy did not produce statistically significant reductions in blood pressure and heart rate among endodontic patients. Alternative methods should be explored to manage patient anxiety better. TRIAL REGISTRATION: The present trial was registered in the Registry of Clinical Trials (IRCT20191228045910N1), available at https://www.irct.ir/trial/46195. © 2025 The Author(s). Clinical and Experimental Dental Research published by John Wiley & Sons Ltd.

09
RANDOMIZED TRIAL (RCT) Complementary therapies in medicine (2025) PMID: 40378898 ↗
The impact of aromatherapy with Citrus bergamia- Lavandula angustifolia essential oil and/or mindfulness-based therapy on postmenopausal health: A factorial randomized controlled trial.
Clinical Trial Synthesis 2025 Randomized Controlled Trial (RCT) published in Complementary therapies in medicine; statistical significance reported at p = 0.05. Key conclusion: CONCLUSION: MBT and LEO-BEO aromatherapy demonstrated favorable outcomes in managing menopausal symptoms and sleep quality.
View Original PubMed Abstract ↓

BACKGROUND: This study aimed to determine the effects of combined aromatherapy with lavender (Lavandula angustifolia Mill.) essential oil (LEO) and Bergamot (Citrus×bergamia (Risso) Risso & Poit) essential oil (BEO) and/or mindfulness-based therapy (MBT) on menopausal symptoms, sleep quality, and serum cortisol. METHODS: This factorial randomized controlled trial included 132 postmenopausal 132 postmenopausal women aged 50-60 years with mild to moderate anxiety. The recruited women were divided into four groups receiving: 1) Control: Usual care + placebo, 2) Therapy: MBT + placebo, 3) Aromatherapy: LEO + BEO Aromatherapy + usual care, and 4) Therapy & Aromatherapy: MBT + LEO-BEO aromatherapy. Participants in the aromatherapy and placebo groups were instructed to apply 2-3 drops of the assigned solution to their forearm skin and inhale it three times daily for eight weeks. Weekly MBT sessions were held over two months. RESULTS: After two months, the aromatherapy group showed reduced total scores for menopausal symptoms [adjusted mean difference (aMD) (95 % CI): -5.7 (-9.5 to -1.8)] and anxiety [aMD (95 % CI): -1.9 (-3.4 to -0.4)] compared to the control group. Sleep quality, measured by the Pittsburgh Sleep Quality Index (PSQI), improved in both the therapy [aMD (95 % CI): -2.6 (-4.2 to -1.0)] and aromatherapy [aMD (95 % CI): -1.7 (-3.3 to -0.1)] groups versus controls. However, the combined intervention showed no significant effects compared to control (p > 0.05). Serum cortisol levels did not differ significantly across groups (p > 0.05). CONCLUSION: MBT and LEO-BEO aromatherapy demonstrated favorable outcomes in managing menopausal symptoms and sleep quality. The combination therapy did not yield additional benefits. The registration number: IRCT20131009014957N8 The registration date: 04/12/2019.

10
RANDOMIZED TRIAL (RCT) Journal of pediatric nursing (2025) PMID: 40288054 ↗
The effect of lavender oil on anxiety before endoscopy in children: A randomized controlled trial.
Clinical Trial Synthesis 2025 Randomized Controlled Trial (RCT) published in Journal of pediatric nursing involving n = 66 participants; statistical significance reported at p = 0.05. Key conclusion: APPLICATION TO PRACTICE: Healthcare professionals can use lavender oil as an aromatherapy method to reduce children's anxiety in clinical settings.
View Original PubMed Abstract ↓

PURPOSE: The aim of this study was to investigate the effect of lavender oil on anxiety before endoscopy in children. DESIGN AND METHODS: This study was a randomized controlled experimental study. The study population consisted of patients aged 9-12 years who were about to undergo endoscopy in a tertiary center. The study sample consisted of 66 children (intervention = 22; placebo = 22; control = 22). Data were collected using a randomized controlled trial with the Sociodemographic Data Collection Form prepared by the researcher and the State-Trait Anxiety Inventory for Children (STAIC) scale. RESULTS: The STAIC state and trait anxiety states of the participants were compared between the groups and no statistically significant difference was found in terms of STAIC trait anxiety scores (p > 0.05). When the STAIC state anxiety scores were compared, it was found that participants in the intervention group had a statistically significantly lower state anxiety score (p < 0.05). CONCLUSIONS: Lavender oil inhalation was effective in reducing pre-procedural anxiety in children. APPLICATION TO PRACTICE: Healthcare professionals can use lavender oil as an aromatherapy method to reduce children's anxiety in clinical settings.

RELATED MONOGRAPHS

Related Monographs in This Category